Veterinary Medicines

Clavoral 500/125 mg tablet for dogs (strength 500 mg amoxicillin + 125 mg

Not authorised
  • Amoxicillin trihydrate
  • Clavulanic acid
Download as PDF

Product identification

Medicine name:
Clavoral 500/125 mg tablet for dogs (strength 500 mg amoxicillin + 125 mg
CLAVUBACTIN 500/125 mg COMPRIMIDOS PARA PERROS
Active substance:
  • Amoxicillin trihydrate
  • Clavulanic acid
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    500.00
    milligram(s)
    /
    1.00
    Tablet
  • Clavulanic acid
    125.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Spain
Package description:
  • Carton containing 5 aluminium/aluminium blister strips each strip with 4 tablets corresponding to 20 tablets per carton.
  • Carton containing 5 aluminium/aluminium blister strips each strip with 2 tablets corresponding to 10 tablets per carton.
  • Carton containing 25 aluminium/aluminium blister strips each strip with 4 tablets corresponding to 100 tablets per carton.
  • Carton containing 25 aluminium/aluminium blister strips each strip with 10 tablets corresponding to 250 tablets per carton.
  • Carton containing 10 aluminium/aluminium blister strips each strip with 10 tablets corresponding to 100 tablets per carton.
  • Carton containing 1 aluminium/aluminium blister strip with 10 tablets corresponding to 10 tablets per carton.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Le Vet. B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 2223 ESP
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0149/003

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/02/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/02/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/02/2024
Download